Loading...
Lonza Group AG
LZAGF•PNK
HealthcareMedical - Diagnostics & Research
$705.25
$19.91(2.90%)
Lonza Group AG (LZAGF) Financial Performance & Statements
Review Lonza Group AG’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
-2.13%
↓ 2.13%
Operating Income Growth
9.55%
↑ 9.55%
Net Income Growth
-2.75%
↓ 2.75%
Operating Cash Flow Growth
-8.01%
↓ 8.01%
Operating Margin
18.46%
↑ 18.46%
Gross Margin
29.21%
↑ 29.21%
Net Profit Margin
8.56%
↑ 8.56%
ROE
6.14%
↑ 6.14%
ROIC
7.65%
↑ 7.65%
Lonza Group AG (LZAGF) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Lonza Group AG stock.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Cash & Cash Equivalents | $1.11B | $1.40B | $1.47B | $1.47B |
| Short Term Investments | $600.00M | $620.00M | $200.00M | $50.00M |
| Cash & Short Term Investments | $1.71B | $2.02B | $1.67B | $1.67B |
| Net Receivables | $1.57B | $1.55B | $1.14B | $1.14B |
| Inventory | $1.73B | $1.71B | $1.58B | $1.58B |
| Other Current Assets | $428.00M | $45.00M | $199.00M | $506.00M |
| Total Current Assets | $5.44B | $5.33B | $4.88B | $4.90B |
| Property Plant & Equipment (Net) | $8.53B | $7.14B | $6.62B | $6.62B |
| Goodwill | $3.37B | $2.85B | $2.75B | $2.75B |
| Intangible Assets | $2.002B | $2.00B | $4.74B | $1.99B |
| Goodwill & Intangible Assets | $5.37B | $4.85B | $7.49B | $4.74B |
| Long Term Investments | $253.00M | $0.00 | $305.00M | $107.00M |
| Tax Assets | $53.00M | $17.00M | $250.00M | $0.00 |
| Other Non-Current Assets | $336.00M | $544.00M | -$2.47B | $482.00M |
| Total Non-Current Assets | $14.29B | $12.56B | $12.20B | $11.95B |
| Total Assets | $19.73B | $17.88B | $17.08B | $16.85B |
| Account Payables | $406.00M | $0.00 | $468.00M | $468.00M |
| Short Term Debt | $468.00M | $155.00M | $227.00M | $191.00M |
| Tax Payables | $136.00M | $123.00M | $137.00M | $0.00 |
| Deferred Revenue | $0.00 | $0.00 | $745.00M | $0.00 |
| Other Current Liabilities | $2.57B | $2.33B | $1.19B | $2.10B |
| Total Current Liabilities | $3.58B | $2.61B | $2.76B | $2.76B |
| Long Term Debt | $4.24B | $3.64B | $2.90B | $2.90B |
| Deferred Revenue Non-Current | $0.00 | $0.00 | $658.00M | $0.00 |
| Deferred Tax Liabilities Non-Current | $493.00M | $0.00 | $726.00M | $0.00 |
| Other Non-Current Liabilities | $2.03B | $2.22B | $754.00M | $1.67B |
| Total Non-Current Liabilities | $6.77B | $5.86B | $4.81B | $4.57B |
| Capital Lease Obligations | $0.00 | $0.00 | $295.00M | $331.00M |
| Total Liabilities | $10.35B | $8.47B | $7.57B | $7.34B |
| Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock | $72.00M | $72.00M | $74.00M | $74.00M |
| Retained Earnings | $9.49B | $9.20B | $9.49B | $9.49B |
| Accumulated Other Comprehensive Income/Loss | $0.00 | -$1.21B | -$1.50B | -$1.50B |
| Total Stockholders Equity | $9.33B | $9.35B | $9.45B | $9.45B |
| Total Equity | $9.39B | $9.41B | $9.51B | $9.51B |
| Total Liabilities & Stockholders Equity | $19.73B | $17.88B | $17.08B | $16.85B |
| Total Investments | $600.00M | $620.00M | $505.00M | $157.00M |
| Total Debt | $5.12B | $3.79B | $3.13B | $3.10B |
| Net Debt | $4.009B | $2.40B | $1.66B | $1.63B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan